Recurrent disease is very common in PC and is associated with very poor oncological outcome, especially when it occurs early . A few available studies on surgical treatment of recurrent disease indicate a potential benefit for only highly selected patients . Therefore, strategies to prevent recurrence are of utmost importance, including quality improvement in surgery andprevention of complications , early detection of improved detection techniques (e.g., fluorescent detection of cancer cells during surgery or F-18-FDG-PET/CT ) and search for more effective intraperitoneal and systemic chemotherapy.